Scott Cormack
2011
In 2011, Scott Cormack earned a total compensation of $683.3K as President and Chief Executive Officer at OncoGenex Pharmaceuticals, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,859 |
|---|---|
| Salary | $499,480 |
| Total | $683,339 |
Cormack received $499.5K in salary, accounting for 73% of the total pay in 2011.
Cormack also received $183.9K in non-equity incentive plan.
Rankings
In 2011, Scott Cormack's compensation ranked 7,016th out of 10,747 executives tracked by ExecPay. In other words, Cormack earned more than 34.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,016 out of 10,747 | 35th |
Division Manufacturing | 2,559 out of 3,960 | 35th |
Major group Chemicals And Allied Products | 616 out of 1,033 | 40th |
Industry group Drugs | 419 out of 781 | 46th |
Industry In Vitro and In Vivo Diagnostic Substances | 21 out of 43 | 51st |
Source: SEC filing on April 24, 2014.
Cormack's colleagues
We found two more compensation records of executives who worked with Scott Cormack at OncoGenex Pharmaceuticals in 2011.